- Staat
- TN
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 01.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dyskinesia
Syncope
Symptomtext
Child fainted within seconds of final vaccine. Cold towel to face. Child regained consciousness, then fainted again and jerked twice before regaining consciousness again. Placed child to lying position with legs elevated, administered O2 @ 6L per mask. EMS called and transported child to ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Dyspnoea
Supine position
Syncope
Throat irritation
Throat tightness
Symptomtext
On May 11, 2022, the patient listed above came in for childhood vaccines. Child was given Hepatitis A 1st dose, Hepatitis B 2nd dose, HPV9 - 1st dose, MMR - 1st dose, TDAP - 2nd dose, and IPV - 1st dose. After patient was given her sixth vaccine, which was the IPV nurse was applying Band-Aids to the patient when patient experienced a syncopal episode. Patient easily aroused within a few seconds. Patient was immediately placed in supine position. Vitals obtained at 09:38 a.m. which where 119/63 HR 64. Patient complained of dizziness and scratchy throat. No difficulty breathing. Remained in clinic for 15 minutes and walked to waiting area on her own accord. Patient was reassessed at 10:00 a.m. in the waiting room and was still complaining of scratchy throat and some dizziness. Patient returned to the clinic area and placed in supine position and vitals reassessed at 10:05 a.m., which were 118/80 HR 65. Patient continued to complain of scratchy tightening throat but no SOB. Decision was made to call EMS for further evaluation at 10:12 a.m. EMS arrived and evaluated patient and recommended transport to the ED for further evaluation and mother declined. Patient left clinic on her own accord accompanied by mother.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None listed on registration
- Vorgeschichte
- None listed on registration
- Andere Medikamente
- None listed on registration
- Allergien
- Pineapple
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood glucose normal
Syncope
Symptomtext
At approx. 2:00 PM after receiving vaccines the patient was walking down the hallway with grandpa and suddenly went down to the floor. The MA called for my help and I got a wheelchair and we assisted the patient back into the exam room and on to the exam table. Vital signs were being taken when Dr. and RN nurse manager) came to evaluate the patient. Dr. ordered a glucose to be done at that time. Vitals and glucose were normal, patient was monitered approx. 15-20 minutes longer and then discharged home with her grandpa.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Vitals Signs: BP 103/64 , Pulse 69, Respirations 16 and Oxygen Sat. 97% room air. Glucose 84
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 16.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal discomfort
Asthenia
Loss of consciousness
Symptomtext
Patient received above listed vaccines in clinic without difficulties at approximately 2:45pm with mom and uncle present in room. Patient was sent to lobby for 10 minutes of monitoring. At 3:00pm front office staff came to nurses room stating patient had passed out and was carried to vehicle by his uncle. Nurse to patient vehicle, alert and oriented x4. vital signs stable. patient stated he began feeling weak and sick to his stomach and then passed out. Stated he now feels "normal".
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 21.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Loss of consciousness
Nervousness
Syncope
Symptomtext
Immediately after receiving vaccinations, client fainted. He lost consciousness for approximately 45 seconds then regained consciousness. Client remained upright in the chair and no injury occurred. He drank water and ate crackers. Client and his mother reported he did not eat breakfast that morning and needles "made him nervous". After 15 minutes of close observation client was feeling "back to normal" and his mother drove him home. They were advised to have him eat more and watch for any other abnormal symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 30.09.2021
- Impfdatum
- 31.08.2021
- Beginn
- 31.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hyperhidrosis
Pallor
Syncope
Symptomtext
Pallor, diaphoresis, syncope
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- none known
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 18.08.2021
- Impfdatum
- 18.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Fatigue
Head injury
Loss of consciousness
Neck injury
Neck pain
Symptomtext
Pt received vaccinations, Then as she was exiting the clinic she passed out, hitting her head and neck in multiple locations. Pt was provided first aid by nurses, Neuro signs were checked, Blood pressure was checked. Pt was evaluated and an ambulance was called based on patient's c/o neck pain, tiredness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Blood Pressure: 1110- 92/56 P- 51; 1115- 95/59, P-50; 1124- 90/51, P-50; 1140-112/80
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 07.08.2021
- Impfdatum
- 07.08.2021
- Beginn
- 07.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Syncope
Symptomtext
Patient involved in near-vasovagal syncopal episode was at front of store when event happened. Pt was able to sit in chair and not fall or lose consciousness. Prior to event, patient was instructed by provider to wait in waiting room for 15 mins for observation. After 15 mins passed receiving vaccination, patient states that she was feeling good and did not have any symptoms. Provider was in the clinic after being notified by pharmacist that a patient "fainted." During patient's recovery, provider took vitals of patient, all which were within normal limits. Provider stayed with patient until she fully recovered and observed her for any additional symptoms. At approx 1828, patient was able to ambulate to outside the store, where provider & patient awaited pt's father to retrieve car. Pt continuously stated that she was feeling better. A follow-up call will be scheduled to check on patient tomorrow.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 19.11.2021
- Impfdatum
- 17.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal dreams
Arthralgia
Dizziness
Fatigue
Injection site erythema
Injection site swelling
Injection site warmth
Myalgia
Pain of skin
Paraesthesia oral
Pruritus
Pyrexia
Symptomtext
By 11-18-2021, injection site swelling with red, raised bump. Increased muscle soreness, area of injection very warm to touch, tingling in tongue and floor of mouth, aching joints and skin, low-grade temperature of 99.4, dizziness, fatigue. Itchiness over the night - dreaming of hives all over face.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma, eczema
- Andere Medikamente
- Vitamin D, Claritin
- Allergien
- Biaxin, Keflex, Flagyl, eggs
- Vorherige Impfungen
- immediate swelling, shortness of breath, age 24 year, 02/1995, flu vaccine - brand unknown lost records
- Staat
- RI
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 28.11.2023
- Impfdatum
- 17.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Pyrexia
Symptomtext
Reported Symptom: 10008531:CHILLS; 10016558:FEVER; Narrative: Pt developed fever and chills for 3 days after receiving Tdap. Other Relevant HX: Other: chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- -
- Geschlecht
- M
- Eingang
- 09.11.2023
- Impfdatum
- 17.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Pyrexia
Symptomtext
Chills; Fever; Patient developed fever and chills for 3 days after receiving Tdap.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 08.08.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Allergy test negative
Erythema
Full blood count normal
Pain in extremity
Rash
Urticaria
Symptomtext
Pt complained of his right arm hurting about 3 1/2-4 hours after vaccine administration. He developed urticarial erythematous hives on his arm & back the following morning at 8am. No lip/throat swelling or itching. No shortness of breath or difficulty breathing. Seen on 7/14/22 in office w/ negative allergy testing & resolution of rash.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Food/Environmental Allergy testing negative. CBC WNL.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Atopic Dermatitis/Eczema
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 03.12.2021
- Beginn
- 04.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Muscle spasms
Musculoskeletal stiffness
Pain in extremity
Symptomtext
Patient was contacted on 2/28/22 about making an appt. for his second Shingrix vaccine. He stated that approx. on 12/4/21 he started to experience leg pain, cramps and stiffness so severe that he had to visit the ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- MRI and other test results pending and unavailable at the time.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Gluten
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 10.01.2022
- Impfdatum
- 20.12.2021
- Beginn
- 21.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Muscular weakness
Symptomtext
Pain in his right shoulder with weakness down his arm. Considering possible SIRVA. He continues to have pain three weeks later, though his weakness is resolving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- metoprolol, turmeric, vitamin d, digestive enzymes
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 21.09.2021
- Beginn
- 22.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature increased
Grip strength decreased
Hyperhidrosis
Pain
Symptomtext
- Elevated temperature noted, patient notes he felt feverish for one day. Sweating lasted one day following immunization. - Since immunization patient reports consistent to worsening grip strength and shooting pains in the arm. Thumb also involved in grip decrease.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- 1) AMPHETAMINE/DEXTROAMPHETAMINE 20MG TAB 40MG ACTIVE MOUTH EVERY DAY 2) CITALOPRAM HYDROBROMIDE 40MG TAB 20MG MOUTH ACTIVE EVERY DAY
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 19.11.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Discomfort
Injection site erythema
Injection site warmth
Pain in extremity
Symptomtext
PATIENT STATES TO HAVE SORENESS TO ARM, PAIN TO UNDERARM, REDNESS AND WARMTH TO INJECTION SITE. PATIENT STATES SHE HAS BEEN TAKING IBUPROFEN WHICH RELIEVES DISCOMFORT. PATIENT HAS NOT SEEKED MEDICAL ATTENTION DUE TO HAVING NO INSURANCE AT THIS TIME.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- DIABETES
- Andere Medikamente
- METFORMIN/GLYBURIDE 500/5 MG; OMEPRAZOLE 20 MG; VITAMIN D 5000 UNITS
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 13.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
Patient presented with dizziness after the vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- NO
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 13.09.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Herpes zoster
Pain
Pyrexia
Rash
Varicella virus test positive
Symptomtext
Patient got onset of Shingles with confirmed viral test from MD. Symptoms includes blisters, pain, rash on lower right back. Also had elevated fever
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- cold sores
- Andere Medikamente
- levothyroxine 50mcg, ondansetron 4mg, periodically take acyclovir 400mg for cold sores
- Allergien
- terbinafine
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 09.09.2021
- Impfdatum
- 30.08.2021
- Beginn
- 31.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Amnesia
Dysphemia
Pain in extremity
Rash
Vision blurred
Symptomtext
Mother reported severe arm pain for 1 week, studdering for 1 week, memory loss of memories the day before, skin rash on face and hands, loss of "eye focus" control. Symptoms are gone now. Patient has not been treated but will be seeing her doctor to get checked.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None specified
- Vorgeschichte
- None specified
- Andere Medikamente
- None specified
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 17.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site pruritus
Injection site swelling
Symptomtext
bruising at site of injection, swelling from site of injection right deltoid to elbow in a line, itching with no rash. no pain anywhere reported by patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- none
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site warmth
Symptomtext
patient has redness and pain surrounding the injection site and continuing up to her shoulder. She complained it was hot and painful. I recommended Tylenol for pain, and Benadryl to help with the redness. She was already using ice to help with the warmth. I will contact her in the morning to check her status, and if no improvement will recommend that she seeks further care at ER or urgent care, or contacts her physician.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- none
- Andere Medikamente
- cyclobenzaprine jardiance pregabalin diclofenac buspirone duloxetine montelukast topiramate fluticasone nasal spray bupropion atorvastatin
- Allergien
- cipro penicillin
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling abnormal
Symptomtext
After receiving both the tdap and MCV4, patient stated he felt light headed, dizzy, and was getting warm. Patient ended up lying down on the table bed in the vaccination room for about three minutes and drank some cool water. After lying down and drinking some water, patient stated he was feeling better and did not feel light headed or dizzy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 20.04.2023
- Impfdatum
- 06.04.2023
- Beginn
- 06.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Tdap vaccine expired 4/1/2023, given 4/6/2023 0 adverse reaction to patient known
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 03.04.2023
- Beginn
- 03.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Boostrix administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 58-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 01-APR-2023) for prophylaxis. On 03-APR-2023, the patient received Boostrix. On 03-APR-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Expired Boostrix administered). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 6-Apr-2023 The office manager called to inquired that how to proceed, the dose was still good. The reporter did not consent to follow-up. The patient inadvertently received an expired dose of Boostrix in reporter's facility, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 11.04.2023
- Impfdatum
- 03.04.2023
- Beginn
- 03.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered an expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 48-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 01-APR-2023) for prophylaxis. On 03-APR-2023, the patient received Boostrix. On 03-APR-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: administered an expired dose). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 03-APR-2023 The reporter consented to follow up. Healthcare professional gave consent for safety team follow up. The patient received a Boostrix vaccine which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 26.11.2022
- Impfdatum
- 15.11.2022
- Beginn
- 15.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Boostrix given in 2018 and 2022; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 15-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included boostrix (dose received on 25th June 2018). On 15th November 2022, the patient received the 2nd dose of Boostrix and Boostrix Pre-Filled Syringe Device. On 15th November 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-NOV-2022 Reporter's Comments: Licensed practical nurse reported on 16th November 2022, that male patient received a dose of Boostrix on 15th November 2022 and they had not realized that the last dose of Boostrix was administered on 25th June 2018. Did not consent to follow-up. The Vaccine Administration Facility was the same as Primary Reporter. Additional Supportive Information: the patient received 2nd dose after receiving 1st dose on 25th August 2018, which led to extra dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 17.09.2022
- Beginn
- 17.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Patient Parent indicated on information form that patient was 7 years old when in actuality patient was 6 years and 8 months old. Patient received TDap instead of Dtap.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NoNE
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 20.04.2022
- Impfdatum
- 10.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 19,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Symptomtext
Patients Inadvertently received additional doses of both Tdap and Menactra. No adverse reaction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 10.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 19,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Symptomtext
patient inadvertently received an additional dose of Tdap. No adverse reactions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 10.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 19,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
patient was inadvertently given a second dose of Tdap. no adverse reaction was reported
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
received Boostrix and Menveo twice; Boostrix on 5/12/2021 and 3/16/2022; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 11-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number gc5ng, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis and Men ACWY-CRM NVS (Menveo) (batch number amva640z, expiry date 30th November 2022) for prophylaxis. Previously administered products included Menveo (received on 12th May 2021) and Boostrix (received on 12th May 2021). On 16th March 2022, the patient received Boostrix (intramuscular) .5 ml, Boostrix Pre-Filled Syringe Device and Menveo (intramuscular) .5 ml. On 16th March 2022, unknown after receiving Boostrix, Boostrix Pre-Filled Syringe Device and Menveo, the patient experienced extra dose administered and drug dose administration interval too short. On an unknown date, the outcome of the extra dose administered and drug dose administration interval too short were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received 1st dose of Menveo on 12th May 2021, 0.5 ml, batch number:amva435a, expiry date : 31st March 2022, intramuscularly in left arm and 1st dose of Boostrix 12th May 2021, 0.5 ml batch number: 33at7, expiry date: 7th November 2022, intramuscularly in right arm. It was stated that, the patient accidently received his Boostrix and Menveo vaccine twice, which led to extra dose administered. The patient received Boostrix in right arm and menveo in left arm. The patient received boostrix earlier than recommended which led to shortening of vaccination schedule. The patient had no symptoms related to this adverse event. The patient consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 14.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Patient had no adverse reactions and is doing fine. Reporting because wrong vaccine was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma
- Andere Medikamente
- Cetirizine HCl 5 mg oral tablet chewable was prescribed on 03/09/22 during the visit.
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 31.08.2021
- Beginn
- 30.10.2021
- Tage bis Beginn
- 60,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Alopecia
Alopecia areata
Anaemia
Blood thyroid stimulating hormone normal
C-reactive protein normal
Full blood count normal
Haemoglobin normal
Madarosis
Mean cell volume normal
Metabolic function test normal
Red blood cell sedimentation rate increased
Trichorrhexis
Symptomtext
Mom reports that on 10/30/2021 after receiving the HPV vaccination, patient noticed increase in hair loss. Patient was seen in Urgent Care 10/30/2021 -mild anemia noted Hg 11.3 normal MCV. remainder of CBC normal. BMP and TSH normal. ESR 23. CRP normal. Was seen at Dermatology on 11/01/2021. Dx with alopecia aerate. Has tried steroids, etc without improvement. Continues to have ongoing hair loss-lost eye lashes, lost 50% of her hair (lots of patches) remainder of hair very brittle.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alopecia
- Hospital-Tage
- -
- Labordaten
- see lab work results listed above
- Aktuelle Erkrankungen
- 7/23/2021 seen in Urgent Care for dysuria-urinalysis did not show any infection at time of well child visit on 8/31/2021-exam showed frequent cardiac ectopy but EKG revealed normal sinus rhythm
- Vorgeschichte
- Scoliosis
- Andere Medikamente
- Ibuprofen 200 mg one time daily as needed Multivitamin gummies-2 daily Sodium Fluoride- no directions listed
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 25.02.2022
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Client scheduled for immunization clinic on 12/13/2021. Client provided vaccine record to the Health Department prior to the immunization clinic. The record was reviewed and entered into immunization system. Prior to immunization clinic, PHNs request copy of client's record to review. Photocopy, that was on file at the Health Department, provided to PHNs. Based upon the record provided, PHNs reached out to medical director, as well as another Public Health Department for assistance on determining what vaccines the client should receive. Due to the record provided to PHNs and what was entered into the immunization system, it was determined that client needed Tdap, MMR, Polio, Varicella, Hep A, meningo, and Flu vaccines. Client was given Hep A, Influenza, Menveo, Bexsero, MMR, and Boostrix as client?s mother reported a history of chicken pox for client. Client scheduled for upcoming vaccination clinic on 2/21/2022. At this time, another copy of the client?s record from past was provided to PHNs. This record contained another photocopied page that was not present on 12/13/2021, and it was noted on the additional information provided that client had received a TD booster on 04/14/2017, and therefore the Boostrix dose given on 12/13/2021 would not have been needed. In order not to miss a vaccination opportunity, client was vaccinated based upon the vaccine record information that was available on 12/13/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- No illness at the time of vaccination.
- Vorgeschichte
- Asthma
- Andere Medikamente
- unknown
- Allergien
- shrimp
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Meningococcal B was given instead of Meningococcal Conjug. No adverse reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 31.01.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Patient was mistakenly administered MMRV (ProQuad), indicated for ages <12, and varicella (Varivax) on same visit. In accordance with vaccine manufacture's health team, patient is eligible to receive second dose of MMR II after 28 days, which would count as the second dose in the series. Called patient's parents/guardian at listed phone number to discuss, but was only able to leave voicemail with callback number. At this time awaiting response.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 09.12.2021
- Impfdatum
- 02.09.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient had no adverse event or outcome. After administration, it was discovered that vaccine refrigerator was out of temp range. Pt is notified and offered re=vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 09.12.2021
- Impfdatum
- 02.09.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient had no adverse event or outcome. After administration, it was discovered that vaccine refrigerator was out of temp range. Pt is notified and offered re=vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 09.12.2021
- Impfdatum
- 08.09.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient had no adverse event or outcome. After administration, it was discovered that vaccine refrigerator was out of temp range. Pt is notified and offered re=vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 09.12.2021
- Impfdatum
- 03.09.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient had no adverse event or outcome. After administration, it was discovered that vaccine refrigerator was out of temp range. Pt is notified and offered re=vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,3
- Geschlecht
- M
- Eingang
- 26.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
15-month-old given Boostrix; given Boostrix instead of DTaP; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. On 22nd November 2021, the patient received Boostrix. On 22nd November 2021, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. Additional details were reported as follows: Pharmacist reported a 15 month old patient had been given Boostrix (TDaP) instead of a dose of DTaP, which led to inappropriate age at vaccine administration and wrong vaccine administered. Reporter consent to follow up by email.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 23.11.2021
- Impfdatum
- 17.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Epistaxis
Symptomtext
Patient reports nosebleeds from the left nostril starting the day after vaccination that has became more frequent as the days has went by.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Epistaxis
- Hospital-Tage
- -
- Labordaten
- None reported
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- Aspirin 325mg po qid
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 17.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
received Boostrix, DOB: 25-FEB-2015; Received Boostrix instead of Flu Vaccine; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included COVID-19 VACCINE (COVID-19 VACCINE UNKNOWN). On 9th November 2021, the patient received Boostrix .5 ml and Boostrix Pre-Filled Syringe Device. On 9th November 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The nurse reported that the 6-year-old patient received Boostrix vaccine in right deltoid instead of Flu vaccine, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This was 1 of 4 case reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021231229:SAME REPORTER US-GLAXOSMITHKLINE-US2021231231:SAME REPORTER US-GLAXOSMITHKLINE-US2021231232:SAME REPORTER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE UNKNOWN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 16.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
received Boostrix, DOB: 04-JUL-2013; received Boostrix instead of Flu vaccine; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included COVID-19 VACCINE (COVID-19 VACCINE UNKNOWN). On 9th November 2021, the patient received Boostrix .5 ml and Boostrix Pre-Filled Syringe Device. On 9th November 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The reporter stated that, the patient received Boostrix vaccine instead of Flu vaccine, which led to inappropriate age at vaccine administration and wrong vaccine administration. The reporter consented to follow up. This is one of four cases reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021231230:SAME REPORTER US-GLAXOSMITHKLINE-US2021231231:SAME REPORTER US-GLAXOSMITHKLINE-US2021231229:SAME REPORTER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE UNKNOWN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
received Boostrix, received Boostrix instead of Flu vaccine; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included COVID-19 VACCINE. On 9th November 2021, the patient received Boostrix .5 ml. On an unknown date, the patient started Boostrix Pre-Filled Syringe Device. On 9th November 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The nurse stated that, the child received Boostrix vaccine instead of Flu vaccine which led to inappropriate age at vaccine administration and wrong vaccine administered The reporter transferred to medical information team for guidance The reporter consented to follow up. This is 1 of the 4 linked cases, reported by the same reporter; Sender's Comments: US-GLAXOSMITHKLINE-US2021231231:SAME REPORTER US-GLAXOSMITHKLINE-US2021231232:SAME REPORTER US-GLAXOSMITHKLINE-US2021231230:SAME REPORTER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 13.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
received Boostrix instead of Flu vaccine; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis and COVID-19 VACCINE for prophylaxis. On 9th November 2021, the patient received Boostrix .5 ml, Boostrix Pre-Filled Syringe Device and COVID-19 VACCINE. On 9th November 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received dose of Boostrix in the left deltoid. The patient received Boostrix vaccine instead of Flu vaccine, which led to wrong vaccine administered. The reporter consented to follow up. This case was 1 of 4 linked cases, reported by same reporter for different patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021231230:SAME REPORTER US-GLAXOSMITHKLINE-US2021231229:SAME REPORTER US-GLAXOSMITHKLINE-US2021231232:SAME REPORTER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 12.10.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
given a dose stored out of range; This case was reported by a other health professional via call center representative and described the occurrence of incorrect product storage in a 26-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 12th October 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incorrect product storage. On an unknown date, the outcome of the incorrect product storage was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter stated that, the patient was given a dose of Boostrix that might have been stored out of range, which led to incorrect product storage. The reporter stated that, the tag alert was red but the fridge log did not have any out of range temperatures. Med info was unable to determine viability as the vaccine was ordered from some other facility. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 18.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
Extra dose administered
Symptomtext
Patient presented to mass flu clinic at the Health Department on 10/15/2021. Vaccine lookup was completed and noted that Patient was behind schedule for MMR, Varicella, Hepatitis A, Tdap, Hepatitis B, and polio. After administration, while documenting immunizations into vaccine system client was searched by name and his birthdate. There were two records for the client, one under Patient's name and DOB and one under Patient's name and DOB. Family was then called to verify middle name that was under, Middle name, mother's maiden name, and DOB match client listed under Patient's in vaccine system. Client had previously received vaccines through Memorial and they had been documenting his immunizations under the wrong name in vaccine system. Client eventually established care at clinic where they documented immunizations under the correct name and DOB for client. Client had two records open in vaccine system with different last names. Both records contain the correct parent information and address. Client has received vaccines at both Memorial and Clinic and some documentation was done under the incorrect last name while some immunizations were documented under the correct name. Due to the client having two open records in vaccine system, client received a total of 4 MMR/Varicella vaccines, 3 Hepatitis A vaccines, and an additional Tdap vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Unknown
- Andere Medikamente
- unknown
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 05.10.2021
- Beginn
- 05.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
16 month old received BOOSTRIX; received BOOSTRIX instead of INFANRIX; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-month-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. On 5th October 2021, the patient received Boostrix. On 5th October 2021, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration and underdose. On an unknown date, the outcome of the inappropriate age at vaccine administration and underdose were unknown. Additional details were reported as follows: The patient received Boostrix instead of Infanrix vaccine, which led to inappropriate age at vaccine administration and underdose. No further details were provided at the time of the call and no adverse reactions were reported. The reporter consented to follow-up
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 01.09.2021
- Impfdatum
- 31.08.2021
- Beginn
- 31.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Child was given a Tdap vaccination that was not age appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Nystatin Topical
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 27.08.2021
- Impfdatum
- 19.08.2021
- Beginn
- 19.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient 5 years of age received Boostrix; Patient received Boostrix instead of Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 19th August 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 19th August 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter was a medical assistant. The patient (5 years of age) received a dose of Boostrix when Kinrix was intended to be given, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 16.08.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tendonitis
Symptomtext
Tendonitis- M 77.9
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tendonitis
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypercholesterolemia, NOS low risk
- Andere Medikamente
- Estradiol 1 mg tablet
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.08.2021
- Impfdatum
- 05.08.2021
- Beginn
- 05.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
administering a dose of BOOSTRIX via prefilled syringe using a BD safety glide (25 gauge) needle/ Product quality complaint ruled out because Luer Lok needle was not used; This case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in device usage process in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 5th August 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 5th August 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced wrong technique in device usage process. The action taken with Boostrix Pre-Filled Syringe Device was unknown. On an unknown date, the outcome of the wrong technique in device usage process was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter was administering to the patient a dose of Boostrix via prefilled syringe using a BD safety glide (25 gauge) needle which led to wrong technique in device usage process. She attempted to inject into an unspecified arm, but the plunger would not push. She did not think the patient received any medication during the attempted administration, so she prepared another dose using a new syringe from the same box and a new needle and was able to successfully administer a complete dose in the opposite arm. Product quality complaint was ruled out because Luer Lok needle was not used. The reporter failed to obtain patient's gender and date of birth. The vaccine administration facility was the same as primary reporter. This case had been linked with case US2021167025, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021167025:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- BOOSTRIX - Prefilled Syringe Device
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.08.2021
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
administering a dose of BOOSTRIX via prefilled syringe using a BD safety glide (25 gauge) needle/Product quality complaint ruled out because Luer Lok needle was not used; This case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in device usage process in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th August 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 4th August 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced wrong technique in device usage process. The action taken with Boostrix Pre-Filled Syringe Device was unknown. On an unknown date, the outcome of the wrong technique in device usage process was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter was administering to the patient a dose of Boostrix via prefilled syringe using a BD safety glide (25 gauge) needle. She attempted to inject into an unspecified arm, but the plunger would not push which led to wrong technique in device usage process. She did not think the patient received any medication during the attempted administration, so she prepared another dose using a new syringe from the same box and a new needle and was able to successfully administer a complete dose in the opposite arm. Product quality complaint was ruled out because Luer Lok needle was not used. The reporter failed to obtain patient's gender and date of birth. The vaccine administration facility was the same as primary reporter. This case had been linked with case US2021167026, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021167026:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -